3/18/11.

Page 1 of 7

SCIENTIFIC PUBLICATIONS 2010, Renal Medicin 1. Akar H, Coskun Akar G, Carrero JJ, Stenvinkel P, Lindholm B. Systemic Consequences of Poor Oral Health in Chronic Kidney Disease Patients. Clin J Am Soc Nephrol. 2010 Nov 29. 2. Alvestrand A, Elinder CG, Lindholm B. Njurmedicin. In: Persson A, Sjöqvist F, editors. Huddinge sjukhus 1972-2002. Stockholm: Karolinska Universitetssjukhuset; 2010. p. 333-41. 3. Avila M, Prado C, Ventura MD, Mora C, Briones D, Valdez H, Hurtado ME, Lindholm B, Qureshi A, Castillo-Henkel C, Paniagua R. Vitamin D receptor gene, biochemical bone markers and bone mineral density in Mexican women on dialysis. Nephrol Dial Transplant. 2010 Feb 2. 4. Baria F, Kamimura MA, Avesani CM, Lindholm B, Stenvinkel P, Draibe SA, Cuppari L. Activity-related Energy Expenditure of Patients Undergoing Hemodialysis. J Ren Nutr. 2010 Nov 3. 5. Bjällmark A, Larsson M, Nowak J, Lind B, Hayashi SY, do Nascimento MM, Riella MC, Seeberger A, Brodin LA. Effects of hemodialysis on the cardiovascular system: quantitative analysis using wave intensity wall analysis and tissue velocity imaging. Heart and vessels. 2010, Nov 10. 6. Bruchfeld A, Richard S. Goldstein, Sangeeta Chavan, Nirav B. Patel, Mauricio Rosas-Ballina, Nina Kohn , Abdul Rashid Qureshi , Kevin J. Tracey. Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in Rheumatoid Arthritis. J Intern Med. 2010 Jul;268(1):94-101. 7. Bruchfeld A, Samiha Benedek, Marie Hilderman, Charlotte Medin, Maarit Korkeila. Rituximab for multirelapsing, steroid-dependent or steroid-resistant, minimal-change nephropathy – a report of nine adult cases. Nephrology Reviews 2010; volume 2:e2 8. Bruchfeld A, Wendt M, Bratt J, Qureshi AR, Chavan S, Tracey KJ, Palmblad K, Gunnarsson I. High Mobility Group Box-1 Protein (HMGB1) is increased in ANCAassociated vasculitis (AAV) with renal manifestations. Mol Med. 2010 Sep 10. [Epub ahead of print]. 9. C Gracia-Iguacel, P Gallar, AR Qureshi, O Ortega, C Mon, M Ortiz, I Villarreal, C Garcia Lacalle, M Sánchez, JC Herrero, A Vigil, B Lindholm and JJ Carrero. Vitamin

3/18/11.

Page 2 of 7

D deficiency in dialysis patients: Impact of dialysis modality and implications on outcome. J Ren Nutr. 2010 Nov;20(6):359-67. 10. Carrero JJ and Stenvinkel P. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal Clin J Am Soc Nephrol. 2009 Dec;4 Suppl 1:S49-55 11. Carrero JJ, Cordeiro AC, Lindholm B, Stenvinkel P. The emerging pleiotropic role of adipokines in the uremic phenotype. Curr Opin Nephrol Hypertens. 2010 Jan;19(1):37-42. 12. Carrero JJ, Nakashima A, Qureshi AR, Lindholm B, Heimbürger O, Bárány P, Stenvinkel P. Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients. Kidney Int. 2010 Dec 22. 13. Carrero JJ, Qureshi AR, Nakashima A, Arver S, Parini P, Lindholm B, Bárány P, Heimbürger O, Stenvinkel P. Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease. Nephrol Dial Transplant. 2010 Jul 11. 14. Carrero JJ, Stenvinkel P Can ghrelin improve appetite in uremic wasting? Nat Rev Nephrol. 2009 Dec;5(12):672-3 15. Carrero JJ, Stenvinkel P. Cardiovascular disease risk factors in chronic kidney disease: traditional, non-traditional and uremia-related threats, Chapter 7 in Cardiorenal Syndrome. Eds Berbari and Mancia, Springer Verlag 2010 16. Carrero JJ, Stenvinkel P. Inflammation in end-stage renal disease – what have we learned in 10 years? Semin Dial. 2010 Sep;23(5):498-509. 17. Carrero JJ, Witasp A, Stenvinkel P, Qureshi AR, Heimbürger O, Bárány P, Suliman ME, Anderstam B, Lindholm B, Nordfors L, Schalling M, Axelsson J. Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels. Nephrol Dial Transplant. 2010 Mar;25(3):901-6. Epub 2009 Nov 30 18. Carrero JJ. Gender differences in chronic kidney disease: underpinnings and therapeutic implications. Kidney Blood Press Res 2010 Oct;33:383-392. 19. Chambers JC, Zhang E et al. genetic loci influencing kidney function and chronic kidney disease in man. Nat Genet. 2010 May;42(5):373-5 20. Chung SH, Han DC, Noh H, Jeon JS, Kwon SH, Lindholm B, Lee HB. Risk factors for mortality in diabetic peritoneal dialysis patients. Nephrol Dial Transplant. 2010 May 5.

3/18/11.

Page 3 of 7

21. Cordeiro AC, Carrero JJ, Bárány P, Qureshi AR, Heimbürger O, Lindholm B, Stenvinkel P Influence of Erythropoiesis-Stimulating Agents on Glycated Hemoglobin in Nondiabetic Kidney Diseases at the Start of Dialysis. Am J Nephrol. 2010 Dec 3;33(1):17-24 22. Cordeiro AC, Qureshi AR, Stenvinkel P, Heimbürger O, Axelsson J, Bárány P, Lindholm B, Carrero JJ. Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. Nephrol Dial Transplant. 2010 Feb;25(2):562-8 23. Covic A, Bammens B, Lobbedez T, Segall L, Heimbürger O, van Biesen W, Fouque D, Vanholder R. Educating end-stage renal disease patients on dialysis modality selection: clinical advice from the European Renal Best Practice (ERBP) Advisory Board. Nephrol Dial Transplant. 2010 Jun;25(6):1757-9. 24. Debowska M, Lindholm B, Waniewski J. Adequacy indices for dialysis in acute renal failure: kinetic modeling. Artif Organs. 2010 May;34(5):412-9. 25. Eckardt K-U, Kim, J, Kronenberg F, Aljama P, Anker SD, Canaud B, Molemans B, Stenvinkel P, Schernthaner G, Ireland E, Fouqueray B, Macdougall. Hemoglobin variability is not an independent predictor of mortality in a European hemodialysis population. J Am Soc Nephrol. 2010 Oct;21(10):1765-75 26. Elinder CG, Vilhelmsdotter Allander S, Farrokhnia N. Skattning av njurfunktion oklart vad som är bästa metod. Bakgrund till SBU:s granskning av endogena markörer Läkartidningen. 2010;107(49):3138-70. 27. Evans M, Elinder CG. Chronic renal failure from lead: myth or evidence-based fact? Kidney Int. 2010 Oct 13. 28. Evans M, Fored CM, Nise G, Bellocco R, Nyren O, Elinder CG. Occupational lead exposure and severe CKD: a population-based case-control and prospective observational cohort study in Sweden. Am J Kidney Dis. 2010 Mar;55(3):497-506. 29. Evans M, Tettamanti G, Nyren O, Bellocco R, Fored CM, Elinder CG. No survival benefit from early-start dialysis in a population-based, inception cohort study of Swedish patients with chronic kidney disease. J Intern Med. 2010 Aug 24. 30. Fehrman-Ekholm I, Bergenhag AC, Heimburger O, Schön S. Recovery of renal function after one-year of dialysis treatment: case report and registry data. Int J Nephrol. 2010 Jun 17;2010:817836.

3/18/11.

Page 4 of 7

31. Francisco ALM, Stenvinkel P, Valount S. Inflammation and its impact on anaemia in chronic kidney disease: from hameglobin variability to hyporesponsiveness. NDT Plus 2009; 2 [Suppl 1]: i18-i26 32. Galach M, Waniewski J, Axelsson J, Heimburger O, Werynski A, Lindholm B. Mathematical Modeling of the Glucose-Insulin System During Peritoneal Dialysis With Glucose-Based Fluids. ASAIO J. 2010 Nov 4. 33. Gracia-Iguacel C, Gallar P, Qureshi AR, Ortega O, Mon C, Ortiz M, Villarreal I, Garcia-Lacalle C, Olieta A, Sánchez M, Herrero JC, Vigil A, Lindholm B, Carrero JJ. Vitamin D Deficiency in Dialysis Patients: Effect of Dialysis Modality and Implications on Outcome. J Ren Nutr. 2010 May 25. 34. Gungor O, Kircelli F, Carrero JJ, Asci G, Toz H, Tatar E, Hur E, Sever MS, Aronsoy T and Ok E. Endogenous testosterone and mortality in male hemodialysis patients; is it the result of aging? Clin J Am Soc Nephrol. 2010 Nov;5(11):2018-23. 35. Hiemstra TF, Walsh M, Mahr A, Savage CO, de Groot K, Harper L, Hauser T, Neumann I, Tesar V, Wissing KM, Pagnoux C, Schmitt W, Jayne DR; for the European Vasculitis Study Group (EUVAS). Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Trial. JAMA. 2010 Dec 1;304(21):2381-8. Epub 2010 Nov 8 36. Jiang N, Qian J, Lin A, Fang W, Cao L, Wang Q, Ni Z, Lindholm B, Axelsson J, Yao Q. Improved plasma amino acids pattern following 12 months of supplemented lowprotein diet in peritoneal dialysis patients. Ren Fail. 2010 Jul;32(6):709-15. 37. Korkeila M, Carrero JJ, Cederholm T, Stenvinkel P. Ghrelin – en ny möjlighet att behandla anorexi och undernäring vid kronisk katabol sjukdom. Läkartidningen;107:1627-28, 2010 38. Lindholm B, Davies S. End-stage renal disease: a new comorbidity index for estimating mortality risk in ESRD. Nat Rev Nephrol. 2010 Jul;6(7):391-3. 39. Luksha N, Luksha L, Carrero JJ, Hammarqvist F, Stenvinkel P, Kublickiene K. Impaired resistance artery function in patients with end-stage renal disease. In POress Clin Sci 2011 40. Meuwese CL, Halbesma N, Stenvinkel P, Dekker FW, Molanaei H, Qureshi AR, Barany P, Heimburger O, Lindholm B, Krediet RT, Boeschoten EW, Carrero JJ.

3/18/11.

Page 5 of 7

Variations in C-reactive protein during a single haemodialysis session do not associate with mortality. Nephrol Dial Transplant. 2010 May 19. 41. Meuwese CL, Snaedal S, Halbesma N, Stenvinkel P, Dekker FW, Qureshi AR, Barany P, Heimburger O, Lindholm B, Krediet RT, Boeschoten EW, Carrero JJ. Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor{alpha} are similarly associated with survival in haemodialysis patients. Nephrol Dial Transplant. 2010 Sep 15. 42. MI Yilmaz, JJ Carrero, JL Martín-Ventura, A Sonmez, M Saglam, H Yaman, M Yenicesu, J Egido, LM Blanco-Colio. Combined therapy with Renin Angiotensin System and Calcium Channel Blockers in Type-2 Diabetic Hypertensive Patients with Proteinuria: Effects on TWEAK, PTX3 and flow mediated dilatation. Clin J Am Soc Nephrol. 2010 Jul;5(7):1174-81. 43. Michael Walsh, Fausta Catapano, Wladimir Szpirt, Kristian Thorlund MSc, Annette Bruchfeld, Loic Guillevin, Marion Haubitz, Peter Merkel, Chen Au Peh, Charles Pusey, David Jayne. Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis. American Journal of Kidney Disease 2010, In Press. 44. Miyamoto T, Rashid Qureshi A, Yamamoto T, Nakashima A, Lindholm B, Stenvinkel P, Alvestrand A, Axelsson J. Postprandial metabolic response to a fat- and carbohydrate-rich meal in patients with chronic kidney disease. Nephrol Dial Transplant. 2010 Nov 23. 45. Molanaei H, Carrero JJ, Heimbürger O, Nordfors L, Lindholm B, Stenvinkel P, OdarCederlöf I, Bertilsson L. Influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with end-stage renal disease Eur J Clin Pharmacol. 2010 Mar;66(3):269-73 46. Muntinghe F, Carrero JJ, Navis, G, Stenvinkel P. TNFa levels are not increased in inflamed patients carrying the CCR5 deletion. Cytokine 2010 47. Nakashima A, Carrero JJ, Qureshi AR, Hirai T, Takasugi N, Ueno T, Taniguchi Y, Lindholm B, Yorioka N. Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients. Osteoporos Int. 2010 Sep 2. 48. Nakashima A, Carrero JJ, Qureshi AR, Miyamoto T, Anderstam B, Bárány P, Heimbürger O, Stenvinkel P, Lindholm B. Effect of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) and the Proinflammatory RAGE Ligand

3/18/11.

Page 6 of 7

(EN-RAGE, S100A12) on Mortality in Hemodialysis Patients. Clin J Am Soc Nephrol. 2010 Sep 16. 49. Nascimento MM, Suliman ME, Silva M, Quinaglia T, Marchioro J, Hayashi SY, Riella M, Lindholm B, Anderstam B. Effect of oral N-Acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: A placebo-controlled study. Perit Dial Int. 2010 Feb 26. PMID: 2019002 50. Olauson H, Qureshi AR, Miyamoto T, Barany P, Heimburger O, Lindholm B, Stenvinkel P, Larsson TE. Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship? Nephrol Dial Transplant. 2010 Apr 5. 51. Sjögren P, Cederholm T, Heimbürger M, Stenvinkel P, Vedin I, Palmblad J, Hellenius ML. Simple advice on life-style habits and long-term changes in biomarkers of inflammation and vascular adhesion in healthy middle-aged men. Eur J Clin Nutr. 2010 Dec;64 (12):1450-6. 52. Stachowska-Pietka J, Waniewski J, Vonesh E, Lindholm B. Changes in free water fraction and aquaporin function with dwell time during continuous ambulatory peritoneal dialysis. Artif Organs. 2010 Dec;34(12):1138-43 53. Stenvinkel P. Chronic kidney disease – a public health priority and harbinger of premature cardiovascular disease. J Intern Med. 2010 Nov;268 (5):456-67 54. Torres C, Aragon A, Gonzalez M, Lopez I, Jakobsson K, Elinder CG, et al. Decreased kidney function of unknown cause in Nicaragua: a community-based survey. Am J Kidney Dis. 2010 Mar;55(3):485-96. 55. Tattersall J, Canaud B, Heimburger O, Pedrini L, Schneditz D, Van Biesen W; European Renal Best Practice advisory Board. High-flux or low-flux dialysis: a position statement following publication of the Membrane Permeability Outcome study.Nephrol Dial Transplant. 2010 Apr;25(4):1230-2. 56. Trimarchi H, Muryan A, Campolo-Girard V, Dicugno M, Barucca N, Lombi F, Young P, Pomeranz V, Forrester M, Alonso M, Iriarte R, Díaz ML, Lindholm B. Elevated Pro-Brain Natriuretic Peptide, Troponin T and Malnutrition Inflammatory Score in Chronic Hemodialysis Patients with Overt Cardiovascular Disease. Nephron Clin Pract. 2010 Aug 30;117(3). 57. Van Biesen W, Heimburger O, Krediet R, Rippe B, La Milia V, Covic A, Vanholder

3/18/11.

Page 7 of 7

R; ERBP working group on peritoneal dialysis. Evaluation of peritoneal membrane characteristics: clinical advice for prescription management by the ERBP working group. Nephrol Dial Transplant. 2010 Jul;25(7):2052-62. 58. Verduijn M, Prein RA, Stenvinkel P, Carrero JJ, le Cessie S, Witasp A, Nordfors L, Krediet RT, Boeschoten EW, Dekker FW. Is fetuin-A a mortality risk factor in dialysis patients or a mere risk marker? A Mendelian randomization approach. Nephrol Dial Transplant. 2011 Jan;26(1):239-45. 59. W Witasp A, Carrero JJ, Heimbürger O, Lindholm B, Hammarqvist F, Stenvinkel P, Nordfors L. Increased expression of pro-inflammatory genes in abdominal subcutaneous fat in advanced chronic kidney disease patients. J Intern Med.2010 Oct 5 60. Waniewski J, Debowska M, Lindholm B. Can the Diverse Family of Dialysis Adequacy Indices Be Understood as One Integrated System? Blood Purif. 2010 Nov 12;30(4):257-265. 61. Witasp A, Carrero JJ, Hammarqvist F, Qureshi AR, Heimbürger O, Schalling M, Lindholm B, Nordfors L, Stenvinkel P. Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease. Eur J Clin Invest. 2010 Dec 3 62. Yamamoto T, Qureshi AR, Anderstam B, Heimbürger O, Bárány P, Lindholm B, Stenvinkel P, Axelsson J. Clinical importance of an elevated circulating chemerin level in incident dialysis patients. Nephrol Dial Transplant. 2010 Jun 13. 63. Yilmaz MI, Qureshi AR, Carrero JJ, Saglam M, Suliman ME, Caglar K, Eyileten T, Cakir E, Oguz Y, Vural A, Yenicesu M, Axelsson J. Predictors of carotid artery intima-media thickness in chronic kidney disease and kidney transplant patients without overt cardiovascular disease. Am J Nephrol 2010 31(3):214-221. 64. Evans M, Tettamantti G, Bellocco R, Nyrén O, Fored CM, Elinder C-G. No survival benefit from early start dialysis in a large, population-based inception cohort of CKDpatients in Sweden J Intern Med 10 SEP (2010).